CDNA — CareDx Inc. stock price and chart

Share this page

CDNA

$64.00-4.01%

as of close, Oct 16, 2026

☾ AH $64.00 -4.01%

CareDx Inc.Stock · HealthcareRussell 2000 0.05%US Stock Market 0.002%Russell 3000 0.002%

PeersMRNALLYMDTUNHJNJTMO

Technical analysis2

Overlay lines0

Addendum charts0

VolumeEEEE

20162019202120242026

10.020.030.040.050.060.070.080.090.0020.0M$64.00

2026-10-16

Price$64.00

MA20$39.71

MA50$26.23

Vol7.3M

What would $1,000 invested in CDNA be worth today? →

CDNA returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $64.00
YTD price return: +239.70%
YTD total return: +239.70%
Next earnings: Nov 3, 2026
Market cap: 3.3B2016-12 57.4M2026-10 3.3B+5668.7% over the window
Enterprise value: 3B
Shares outstanding: 51.7M2016-06 19M2026-06 51.7M+172.6% over the window
52W low: $14.03
52W high: $72.51
From 52W high: -11.74%
From 52W low: +356.17%
52W range: 85%

Volume

Rel volume: 1.07×
30D volume: 1.4M
30D $ vol: 84.2M

Fundamentals

Sales (ttm): 458.1M2016-06 31.1M2026-06 458.1M+1373.1% over the window
Sales/share: $8.852016-06 $1.642026-06 $8.85+440.4% over the window
EPS (ttm): $2.102016-06 -$2.272026-06 $2.10-192.5% over the window
FCF (ttm): 40M2015-12 -11M2019-09 -1.6M-85.2% over the window
FCF/share: $0.772015-12 -$0.922019-09 -$0.04-95.8% over the window
Book value/share: $8.232016-06 $1.682026-06 $8.23+389.4% over the window
Net margin: 24.23%2016-06 -91.6%2026-06 24.2%-126.5% over the window
ROE: 26.08%2016-06 -89.3%2026-06 26.1%-129.2% over the window
ROA: 20.83%2016-06 -28.3%2026-06 20.8%-173.5% over the window
Current ratio: 4.582016-06 0.852026-06 4.58+439.7% over the window

Growth (CAGR, ttm) · 10Y

Sales: +34.43%2025-06-30 → 2026-06-30340.8M → 458.1M (+34.4% total)+13.98%2023-06-30 → 2026-06-30309.3M → 458.1M (+48.1% total)+12.56%2021-06-30 → 2026-06-30253.6M → 458.1M (+80.6% total)+30.87%2016-06-30 → 2026-06-3031.1M → 458.1M (+1373.1% total)
Net income: +91.03%2025-06-30 → 2026-06-3058.1M → 111M (+90.9% total)n/an/an/a
Shares: -2.81%2025-06-30 → 2026-06-3053.2M → 51.7M (-2.8% total)-1.52%2023-06-30 → 2026-06-3054.2M → 51.7M (-4.5% total)-0.34%2021-06-30 → 2026-06-3052.6M → 51.7M (-1.7% total)+10.55%2016-06-30 → 2026-06-3019M → 51.7M (+172.6% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +109.80%2025-06-30 → 2026-06-30$1.00 → $2.10 (+109.7% total)n/an/an/a
Sales/share: +38.31%2025-06-30 → 2026-06-30$6.40 → $8.85 (+38.3% total)+15.74%2023-06-30 → 2026-06-30$5.71 → $8.85 (+55.1% total)+12.94%2021-06-30 → 2026-06-30$4.82 → $8.85 (+83.8% total)+18.38%2016-06-30 → 2026-06-30$1.64 → $8.85 (+440.4% total)
Book value/share: +33.78%2025-06-30 → 2026-06-30$6.15 → $8.23 (+33.8% total)+3.22%2023-06-30 → 2026-06-30$7.48 → $8.23 (+10.0% total)-2.04%2021-06-30 → 2026-06-30$9.12 → $8.23 (-9.8% total)+17.21%2016-06-30 → 2026-06-30$1.68 → $8.23 (+389.4% total)
Price: +327.38%2025-10-16 → 2026-10-16$14.99 → $64.00 (+327.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+122.97%2023-10-16 → 2026-10-16$5.77 → $64.00 (+1009.2% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-2.05%2021-10-15 → 2026-10-16$71.00 → $64.00 (-9.9% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+32.97%2016-10-14 → 2026-10-16$3.70 → $64.00 (+1629.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +327.38%2025-10-16 → 2026-10-16$14.99 → $64.00 (+327.0% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+122.97%2023-10-16 → 2026-10-16$5.77 → $64.00 (+1009.2% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-2.05%2021-10-15 → 2026-10-16$71.00 → $64.00 (-9.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+32.97%2016-10-14 → 2026-10-16$3.70 → $64.00 (+1629.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 30.5×2016-12 -2.002026-10 29.85-1593.8% over the window
Fwd P/E: 49.2×
P/S (ttm)Market cap ÷ TTM revenue.: 7.2×2016-12 1.582026-10 7.23+358.6% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 7.8×2016-12 1.592026-10 7.79+390.7% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 82.8×2016-12 -3.172026-10 -2048.27+64578.5% over the window
EV/EBITDA (fy): 24.1×
EV/Sales (ttm): 6.5×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 1.21%2016-09 -31.6%2019-09 -0.2%-99.5% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 51.7M ÷ 53.2M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: 2.81%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (2.81%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($1B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 2.81%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($50M) ÷ today's market cap ($3.3B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 1.51%2016-09 0.0%2026-06 3.4%
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $50M + TTM dividends $0) ÷ today's market cap ($3.3B). Same caveat as the cash buyback yield.: 1.51%2016-09 0.0%2026-06 3.4%

Vs own 10Y history

P/S: 64th
P/B: 67th

Bar = where today’s multiple sits in CDNA’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-16#

-4.01%

+0.52%

+19.51%

+58.65%

YTD

+239.70%

+326.95%

-9.86%

Financial statements

Open full CDNA financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+10.48%	+0.43%
JNJ	Johnson & Johnson	-4.38%	+0.90%
ABBV	AbbVie Inc.	+8.73%	+0.71%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+6.97%	-1.29%
MRK	Merck & Co. Inc.	+0.72%	+0.52%
NVS	Novartis AG	+8.59%	+0.16%
TMO	Thermo Fisher Scientific Inc.	+6.41%	-0.93%
AMGN	Amgen Inc.	+14.92%	-0.35%

CDNA — CareDx Inc. price, chart and key statistics